Eurizon Capital SGR S.p.A. Makes New Investment in Corteva, Inc. $CTVA

Eurizon Capital SGR S.p.A. acquired a new position in shares of Corteva, Inc. (NYSE:CTVA) during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund acquired 704,242 shares of the company’s stock, valued at approximately $47,206,000. Eurizon Capital SGR S.p.A. owned about 0.10% of Corteva at the end of the most recent reporting period.

Several other large investors also recently added to or reduced their stakes in CTVA. JPL Wealth Management LLC bought a new stake in Corteva during the third quarter worth approximately $25,000. Redmont Wealth Advisors LLC bought a new stake in Corteva during the third quarter worth approximately $29,000. Jackson Grant Investment Advisers Inc. increased its stake in Corteva by 90.6% during the third quarter. Jackson Grant Investment Advisers Inc. now owns 448 shares of the company’s stock worth $30,000 after acquiring an additional 213 shares during the last quarter. Basepoint Wealth LLC purchased a new position in shares of Corteva during the fourth quarter valued at approximately $30,000. Finally, KERR FINANCIAL PLANNING Corp purchased a new position in shares of Corteva during the third quarter valued at approximately $33,000. 81.54% of the stock is owned by institutional investors.

Corteva Stock Down 2.7%

Shares of NYSE CTVA opened at $78.41 on Friday. The company has a debt-to-equity ratio of 0.07, a quick ratio of 1.03 and a current ratio of 1.47. The firm has a market capitalization of $52.44 billion, a price-to-earnings ratio of 46.12, a PEG ratio of 2.39 and a beta of 0.59. The stock has a 50 day moving average price of $81.33 and a 200 day moving average price of $74.53. Corteva, Inc. has a 52-week low of $60.53 and a 52-week high of $85.63.

Corteva (NYSE:CTVA) last announced its quarterly earnings results on Tuesday, May 5th. The company reported $1.50 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.18 by $0.32. The firm had revenue of $4.91 billion during the quarter, compared to analyst estimates of $4.64 billion. Corteva had a return on equity of 9.95% and a net margin of 6.50%.Corteva’s quarterly revenue was up 11.0% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.13 earnings per share. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. Sell-side analysts expect that Corteva, Inc. will post 3.72 earnings per share for the current year.

Corteva Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Monday, June 15th. Shareholders of record on Monday, June 1st will be issued a dividend of $0.18 per share. The ex-dividend date is Monday, June 1st. This represents a $0.72 dividend on an annualized basis and a yield of 0.9%. Corteva’s dividend payout ratio is currently 42.35%.

Wall Street Analyst Weigh In

Several brokerages have issued reports on CTVA. The Goldman Sachs Group boosted their target price on Corteva from $88.00 to $96.00 and gave the company a “buy” rating in a research report on Tuesday, April 14th. CICC Research boosted their target price on Corteva from $80.00 to $93.00 and gave the company an “outperform” rating in a research report on Wednesday, May 13th. Argus boosted their target price on Corteva from $80.00 to $91.00 and gave the company a “buy” rating in a research report on Tuesday, March 31st. Weiss Ratings upgraded Corteva from a “hold (c)” rating to a “hold (c+)” rating in a research report on Thursday, May 7th. Finally, Wall Street Zen lowered Corteva from a “buy” rating to a “hold” rating in a report on Saturday, February 7th. Fourteen research analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $88.67.

Corteva Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.